Alerts

Stryker Australia has issued a hazard alert to surgeons regarding its Oasys Midline Occipital Plate.

Recall for product correction for Medtronic SynchroMed II and SynchroMed EL implantable infusion pumps.

Viaplus Gold capsules pose a serious risk to your health and should not be taken. They contain undeclared contain the undeclared sildenafil and have not been assessed for quality, safety or efficacy.

Majestic Slim Perfect capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and phenolphthalein. Both substances have serious safety concerns.

Plexus Slim Accelerator capsules and the 3-Day Trial Pack are unsafe and illegal in Australia because they contain banned substance 1,3-dimethylamylamine (DMAA). This can cause serious health problems.

Consumers and health professionals are advised that Medtronic Australasia, in consultation with the TGA, is recalling certain batches of the Medtronic MiniMed insulin reservoirs.

Health professionals and consumers are advised that Medtronic Australasia is issuing a hazard alert for its Consulta Cardiac Resynchronization Therapy Pacemaker (CRT-P).

Hydroxyethyl starch (Voluven and Volulyte) and increased risk of mortality

B. Braun Australia is withdrawing the cementless version of the Columbus Knee System from the Australian Register of Therapeutic Goods (ARTG). They have also issued a related hazard alert to surgeons.

GE Healthcare has initiated a recall for product correction for a number of its nuclear medicine imaging systems.

Nite Rider capsules pose a serious risk to your health and should not be taken. They contain undeclared yohimbine and have not been assessed for quality, safety or efficacy.

Synthes Australia, in consultation with the TGA, is recalling unused stock of its 3.7 mm and 5.0 mm Dynamic Locking Screws.

Maxman IX Capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.

Medtronic has initiated a recall of unused stock of multiple lots of its Infuse/LT-Cage Bone Graft Kit.

Medtronic has initiated a recall for product correction for its Medtronic Paradigm insulin infusion sets.

The TGA advises that GNY Australia has initiated a recall of GNY Slimming Pills - labelled as MSV (Strong Version), ESV (Extra Strong Version) and GRL (Rapid Loss Soft Gel Capsules) - as they pose a serious health risk.

Johnson & Johnson Medical is issuing a hazard alert to implanting surgeons regarding one lot of its Glenosphere Orientation Guide (lot number 5120443).

Yong Gang tablets pose a serious risk to your health and should not be taken. They contain undeclared tadalafil and sildenafil and have not been assessed for quality, safety or efficacy.

MMC Maxman V capsules pose a serious risk to your health and should not be taken. The contain undeclared sildenafil and phenolphthalein, which has serious safety concerns.

TGA safety alert on cyproterone + ethinyloestradiol products (e.g. Diane‑35) highlights an increased risk of blood clots, advising careful patient selection while noting benefits outweigh risks when used as approved.

Johnson & Johnson Medical has initiated a recall of all unused stock and issued a hazard alert to implanting surgeons for two Codman Certas Programmable Valve products.

The TGA has issued updated safety advice for health professionals regarding dabigatran (Pradaxa), highlighting the increased risk of bleeding and the importance of careful patient selection and monitoring, especially in older adults and those with kidney impairment.

TGA has issued updated safety advice for consumers taking Pradaxa (dabigatran), highlighting risks such as bleeding and the importance of proper storage and patient monitoring.

Health professionals and consumers are advised that Roche Diagnostics Australia, after consultation with the TGA, has initiated a recall for product correction for its CoaguChek XS, CoaguChek XS Plus and CoaguChek XS Pro INR monitors.

Gardasil is a vaccine that protects males and females from a range of cancers (including cervical and anal cancers) and other diseases caused by human papillomavirus (HPV). It is administered as three injections over six months.